Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY).

Full DD Report for CHGCY

You must become a subscriber to view this report.


Recent News from (OTC: CHGCY)

Chugai Pharmaceutical Co., Ltd. ADR 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: July, 27 2018 14:42
Alexion Pharmaceuticals: Clinical Progress, Acquisitions And The Competition (Part 2)
This article is the second of two parts discussing Alexion Pharmaceuticals ( ALXN ) and its competition. Make sure to check out Part 1 here if you have not already. In Part 2 I will focus mostly on ALXN’s competition. I have previously reviewed a large number of ALXN’s compet...
Source: SeekingAlpha
Date: May, 31 2018 09:04
Chugai Pharmaceutical Co., Ltd. ADR 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 25 2018 14:07
Week In Review: James Watson To Lead New Shenzhen Biopharma Research Center
Industry Developments James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area. A groundbreaking ceremony was held last Friday with Dr. Watson i...
Source: SeekingAlpha
Date: March, 25 2018 09:31
Chugai Pharmaceutical Co., Ltd. ADR 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 02 2018 14:12
Chugai Pharmaceutical Co., Ltd. ADR 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 25 2017 14:24
Roche: Buying The Dip
Introduction Roche Holding ( RHHBY ), based in Switzerland, controls 100% of the world's largest and most prominent biotech firm, Genentech; and all of the world's largest diagnostic company. The latter generates about 22% of RHHBY's sales. Depending on currency translations between the S...
Source: SeekingAlpha
Date: October, 25 2017 11:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-18N/A129.25N/AN/A50
2018-12-17N/A129.25N/AN/A0
2018-12-14N/A129.25N/AN/A22
2018-12-13N/A129.25N/AN/A66
2018-12-12N/A129.25N/AN/A6

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0752186959.9540Short
2018-11-237777100.0000Short
2018-09-182525100.0000Short
2018-08-073,8005,55468.4192Short
2018-07-265848112.0582Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CHGCY.


About Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY)

Logo for Chugai Pharmaceutical Co., Ltd. (OTC: CHGCY)

Chugai Pharma Manufacturing Co., Ltd. is commissioned to manufacture pharmaceuticals.

 

Contact Information

 

 

Current Management

  • Motoo Ueno / Deputy Chairman
  • Osamu Nagayama / CEO
  • Tatsuro Kosaka / President, COO
  • Osamu Nagayama / Chairman
  • Yoshio Itaya /
  • Tatsumi Yamazaki /

Current Share Structure

  • Market Cap: $28,824,035,000 - 03/09/2018
  • Issue and Outstanding: 559,690,000 - 02/28/2013

 



Daily Technical Chart for (OTC: CHGCY)

Daily Technical Chart for (OTC: CHGCY)


Stay tuned for daily updates and more on (OTC: CHGCY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CHGCY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHGCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CHGCY and does not buy, sell, or trade any shares of CHGCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/